Chemplast Sanmar Limited share price

NSE: CHEMPLASTS · ISIN INE488A01050

Key numbers

Market cap
₹ 3,122 Cr
Current price
₹ 197.47
52-week high / low
₹ 422 / 161
Stock P/E
-
Book value
₹ 111.0
Dividend yield
0.00%
ROCE
-6.3%
ROE
-14.6%
Debt to equity
1.11
Sales growth (3 yrs)
-5.1%
Profit growth (3 yrs)
-
1-year return
-53.0%

About Chemplast Sanmar Limited

Chemplast Sanmar Limited engages in manufacturing and selling of specialty chemicals in India. The company offers specialty paste PVC resins; custom manufactured chemicals, such as organic chemicals, and phyto chemicals comprising colchicine and thiocolchicoside; and hydrogen peroxide. It also provides caustic chlor products, including caustic soda lye and flakes, chlorine, hydrochloric acid, and hydrogen; refrigerant gas, that includes hydrochlorofluorocarbons under the Mettron brand name; and solvents comprising chloromethanes products, such as methyl chloride, methylene dichloride, chloroform, and carbon tetrachloride. The company offers its products for agrochemical, pharmaceutical, fine chemicals, paper, textile, water treatment, bleaching, and effluent treatments. It also exports its products. The company was formerly known as Chemicals and Plastics India Limited and changed its name to Chemplast Sanmar Limited in September 1995. Chemplast Sanmar Limited was incorporated in 1962 and is based in Chennai, India. Chemplast Sanmar Limited is a subsidiary of Sanmar Holdings Limited.

Quarterly results

Consolidated figures in ₹ crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,1001,0338351,2561,125
Operating profit1743-57194-115
Net profit-64-51-119-45-176
EPS (₹)-4.02-3.21-7.45-2.87-11.10

Concall summary (2026-08-14)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

  • However, the market turned around in June as Middle East situation eased, providing better visibility on raw material availability and helping downstream operating rates to recover to 70% to 80%.
  • Backed by a healthy order book, acceler ating customer engagements and robust product pipeline, we are confident that this positive momentum will continue through FY27.

Growth & demand

  • Our molecule pipeline has expanded close to 50 molecules with 14 being commercialized, reinforcing our confidence in the long-term growth prospects of the business.
  • While demand for caustic soda remained stable across key end user industries, chloromethanes volumes were impacted by softer demand in select end -use segments.

Margins & costs

  • However, a sharp increase in input costs severely impacted profitability, resulting in EBITDA loss of INR115 crores.
  • To support the domestic economy and reduce import costs, the government exempted customs duty on PVC resin and reduced the duty from 2% on VCM to nil from 2nd April to 30th June 2026.

Capex & expansion

  • On the new plant, project commissioning is underway and progressing as per plan.
  • That has now eased out and plants have started going back to their 70%, 80%, 90% capacity.

Balance sheet & cash

  • That, along with the current accruals, will take care of all the debt servicing obligations.

Peers in Chemicals

Data for information only, not investment advice. Prices end of day.